Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005 / Marie N. Stagnitti.

Format:

Book

Government document

Author/Creator:

Stagnitti, Marie N.

Contributor:

United States. Agency for Healthcare Research and Quality

Medical Expenditure Panel Survey (U.S.)

Series:

Statistical brief (Medical Expenditure Panel Survey (U.S.)) ; #205.

Statistical brief ; #205

Language:

English

Subjects (All):

Drug utilization--Economic aspects--United States.

Drug utilization.

Prescription pricing--United States.

Prescription pricing.

Statins (Cardiovascular agents)--United States.

Statins (Cardiovascular agents).

Hydroxymethylglutaryl-CoA Reductase Inhibitors--economics.

Prescriptions, Drug.

United States.

Drug utilization--Economic aspects.

Medical Subjects:

Hydroxymethylglutaryl-CoA Reductase Inhibitors--economics.

Prescriptions, Drug.

United States.

Genre:

Statistics

Statistics.

Physical Description:

1 online resource (6 unnumbered pages)

Place of Publication:

[Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2008]

Summary:

This Statistical Brief examines trends for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly know as statins, for the years 2000 and 2005. The data included in this brief are derived from 2000 and 2005 data for the U.S. civilian noninstitutionalized population from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC). The brief compares 2000 and 2005 total expenditures, total number of purchases, and total number of persons purchasing, as well as average total expenditure and average number of purchases of statins for those with one or more statin purchases.

Notes:

Title from title screen (viewed September 12, 2008).

"May 2008."

Includes bibliographical references.

OCLC:

233049818